Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | FFAR2 | O15552 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3826730 | 0.81 | ACE (0.37) | ACEALDH1A1FFAR2 | |
| SCHEMBL25426819 | 0.81 | FFAR2 (0.34) | ACEALDH1A1FFAR2 | |
| SCHEMBL6034101 | 0.78 | GAA (0.34) | ACEALDH1A1FFAR2 | |
| SCHEMBL6033119 | 0.78 | GAA (0.34) | ACEALDH1A1FFAR2 | |
| SCHEMBL22444297 | 0.78 | FFAR2 (0.35) | ACEALDH1A1FFAR2 | |
| SCHEMBL20819892 | 0.78 | FFAR2 (0.35) | ACEALDH1A1FFAR2 | |
| SCHEMBL20819885 | 0.78 | FFAR2 (0.35) | ACEALDH1A1FFAR2 | |
| SCHEMBL22371723 | 0.78 | FFAR2 (0.35) | ACEALDH1A1FFAR2 | |
| SCHEMBL25251989 | 0.78 | ACE (0.32) | ACEALDH1A1 | |
| SCHEMBL6034100 | 0.76 | FFAR2 (0.36) | ACEALDH1A1FFAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2850075-A1 | PIPERAZINE-PIPERIDINE COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | Theravance Biopharma R&D IP, LLC (US) | 2015-03-25 | — | — | EP | disclosed |
| WO-2013163262-A1 | PIPERAZINE-PIPERIDINE COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | THERAVANCE, INC. (US) | 2013-10-31 | — | — | WO | disclosed |
| EP-2635571-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS | Theravance, Inc. (US) | 2013-09-11 | — | — | EP | disclosed |
| WO-2012061552-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS | THERAVANCE, INC. (US) | 2012-05-10 | — | — | WO | disclosed |